Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock Forecast
Alert
Its only available to paid users.
INR 1,726.13
(-10.10%)
Based on the Sun Pharmaceutical Industries Limited stock forecast from 6 analysts, the average analyst target price for Sun Pharmaceutical Industries Limited is INR 1,726.13 over the next 12 months. Sun Pharmaceutical Industries Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Sun Pharmaceutical Industries Limited is Slightly Bullish , which is based on 6 positive signals and 4 negative signals. At the last closing, Sun Pharmaceutical Industries Limited’s stock price was INR 1,919.95. Sun Pharmaceutical Industries Limited’s stock price has changed by +2.64% over the past week, +5.73% over the past month and +65.71% over the last year.
No recent analyst target price found for Sun Pharmaceutical Industries Limited
No recent average analyst rating found for Sun Pharmaceutical Industries Limited
Company Overview Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India. Read Less
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, i...Read More
Frequently Asked Questions About Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock
Based on ratings from 6 analysts Sun Pharmaceutical Industries Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 5 buy, sell and 3 hold ratings.
SUNPHARMA:NSE stock's dividend yield is 0.72%.
Our analysis grades SUNPHARMA:NSE stock's dividend yield at C-. This means that SUNPHARMA:NSE stock's dividend yield is above 71% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange.
Based on this SUNPHARMA:NSE may be a average dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for SUNPHARMA:NSE is INR 1,726.13 over the next 12 months. The maximum analyst target price is INR 1870 while the minimum anlayst target price is INR 1400.
SUNPHARMA:NSE stock's Price/Earning ratio is 43.93.
Our analysis grades SUNPHARMA:NSE stock's Price / Earning ratio at F. This means that SUNPHARMA:NSE stock's Price/Earning ratio is above 46% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange.
Based on this SUNPHARMA:NSE may be fairly valued for its sector
The last closing price of SUNPHARMA:NSE's stock was INR 1,919.95.
The most recent market capitalization for SUNPHARMA:NSE is INR 4,554.89B.
Based on targets from 6 analysts, the average taret price for SUNPHARMA:NSE is projected at INR 1,726.13 over the next 12 months.
This means that SUNPHARMA:NSE's stock price may go down by -10.10% over the next 12 months.
We can't find any ETFs which contains Sun Pharmaceutical Industries Limited's stock.
As per our most recent records Sun Pharmaceutical Industries Limited has 43,000 Employees.
Sun Pharmaceutical Industries Limited's registered address is Sun House, Mumbai, India, 400063.
You can get more information about it from Sun Pharmaceutical Industries Limited's website at https://www.sunpharma.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Sun Pharmaceutical Industries Limited (SUNPHARMA:NSE) Stock
Based on ratings from 6 analysts Sun Pharmaceutical Industries Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 5 buy, sell and 3 hold ratings.
SUNPHARMA:NSE stock's dividend yield is 0.72%.
Our analysis grades SUNPHARMA:NSE stock's dividend yield at C-. This means that SUNPHARMA:NSE stock's dividend yield is above 71% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange.
Based on this SUNPHARMA:NSE may be a average dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for SUNPHARMA:NSE is INR 1,726.13 over the next 12 months. The maximum analyst target price is INR 1870 while the minimum anlayst target price is INR 1400.
SUNPHARMA:NSE stock's Price/Earning ratio is 43.93.
Our analysis grades SUNPHARMA:NSE stock's Price / Earning ratio at F. This means that SUNPHARMA:NSE stock's Price/Earning ratio is above 46% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange.
Based on this SUNPHARMA:NSE may be fairly valued for its sector
The last closing price of SUNPHARMA:NSE's stock was INR 1,919.95.
The most recent market capitalization for SUNPHARMA:NSE is INR 4,554.89B.
Based on targets from 6 analysts, the average taret price for SUNPHARMA:NSE is projected at INR 1,726.13 over the next 12 months.
This means that SUNPHARMA:NSE's stock price may go down by -10.10% over the next 12 months.
We can't find any ETFs which contains Sun Pharmaceutical Industries Limited's stock.
As per our most recent records Sun Pharmaceutical Industries Limited has 43,000 Employees.
Sun Pharmaceutical Industries Limited's registered address is Sun House, Mumbai, India, 400063.
You can get more information about it from Sun Pharmaceutical Industries Limited's website at https://www.sunpharma.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SUNPHARMA:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Join over half-million smart investors across the world
Loading...
The Adjusted Closing and Unadjusted Closing sections display stock prices with and without adjustments, respectively. The Share Trading Volume section shows the stocks trading volume over time, indicating market activity. The Compare Performance section allows you to analyze a stocks performance against others by entering symbols and clicking Add to see relative returns. These tools aid in making informed investment decisions. Use the date range selectors to view trends from the past month (1m), three months (3m), six months (6m), year-to-date (YTD), one year (1y), five years (5y), or all available data (All).
